References
- AttarEAromatase and other steroidogenic genes in endometriosis. Translational aspectsHum Reprod Update200612495616123052
- MaiaHJrHaddadCCasoyJCorrelation between aromatase expression in the eutopic endometrium and the presence of endometriosisInt J Women’s Health201246165
- MaiaHJrCasoyJValente FilhoJIs aromatase expression in the endometrium the cause of endometriosis and its related infertility?Gynecol Endocrinol20092525319340622
- GuoSWNuclear factor-kappaB (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large?Gynecol Obstet Invest200763719717028437
- AmsterdamLLGentryWJobanputraSWolfMRubinSDBulunSEAnastrazole and oral contraceptives: a novel treatment for endometriosisFertil Steril20058430030416084868
- BulunSEZeitounKMTakayamaKSasanoHMolecular basis for treating endometriosis with aromatase inhibitorsHum Reprod Update2000641341811045871
- MaiaHJrCasoyJCorreiaTThe effects of oral contraceptives on aromatase expression in the eutopic endometrium of patients endometriosisGynecol Endocrinol20082412312818335325
- MaiaHJrCasoyJNon contraceptive health benefits of oral contraceptivesEur J Contracept Reprod Health Care200813172417963179
- FechnerSHusenBTholeHExpression and regulation of estrogen converting enzymes in ectopic human endometrial tissueFertil Steril200788Suppl1029103817316633
- YamanakKXuBSuganumaIDienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic stroma cells in spheroid culturesFertil Steril20129747748222130322
- HatokJZuborPGaloSEndometrial aromatase mRNA as a possible screening tool for advanced endometriosis and adenomyosisGynecol Endocrinol20102733133620553220
- KitawakiJKadoNIshiharaHKoshibaHKitaokaYHonjoHEndometriosis: the pathophysiology as estrogen dependent diseasesJ Steroid Biochem Mol Biol20028314915512650711
- HarikumarKBAggarwalBBResveratrol: a multitargeted agent for age-associated chronic diseaseCell Cycle200871020103518414053
- Bruner-TranKLOsteenKGTaylorHSSokalskaAHainesKDulebaAJResveratrol inhibits development of experimental endometriosis in vivo and reduces endometrial stromal cell invasiveness in vitroBiol Reprod20118410611220844278
- MabroukMSolfriniSFrascàCA new oral contraceptive regimen for endometriosis management: preliminary experience with 24/4-day drospirenone/ethinylestradiol 3 mg/20 mcgGynecol Endocrinol20122845145422132832
- BiberogluKOBehrmanSJDosage aspects of danazol therapy in endometriosis: short term and long term effectivenessAm J Obstet Gynecol19811396456546452062
- VercelliniPFrontinoGDe GiorgiOAimiGZainaBCrosignaniPGComparison of a levonorgestrel intrauterine releasing device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot studyFertil Steril20038030530912909492
- FonteinDBNortierJWLiefersGJHigh non-compliance in the use of letrozole after 2.5 years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trialEur J Surg Oncol20123811011722172646
- WangYLeungLKPharmacological concentration of resveratrol suppresses aromatase in JEG-3 cellsToxicol Lett200717317518017766065
- JangMPezzutoJMCancer chemopreventive activity of resveratrolDrugs Exp Clin Res199925657710370867
- ShakibaeiMBuhrmannCMobasheriAResveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-kappaB ligand (RANKL) activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cellsJ Biol Chem2011286114921150521239502
- RyuJKuBMLeeYKResveratrol reduces TNF-α-induced U373M human glioma cell invasion through regulating NF-κB activation and uPA/uPAR expressionAnticancer Res2011314223423022199285
- NobleLSProstaglandin E2 stimulates aromatase activity in endometriosis derived stromal cellsJ Clin Endocrinol Metab1997826006069024261
- MaiaHJrCasoyJCorreiaTActivation of NF-KappaB and Cox-2 expression is associated with breakthrough bleeding in patients using oral contraceptives in extended regimensGynecol Endocrinol20102626526919757243